Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1167557 Greenwich, CT
Back to AMRX Full portfolio

Position in AMRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,761,931
+$3,012,569 QoQ
Shares Held
795,028
-8.1% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 311 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. AMRX ranks #11 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 3,818,037 $643,491,951
2 UTHR
UNITED THERAPEUTICS Corp
 546,002 $295,840,259
3 ZTS
Zoetis Inc.
 1,070,929 $76,956,955
4 VTRS
Viatris Inc
 4,694,966 $74,556,056
5 PRGO
PERRIGO Co plc
 3,480,666 $36,164,117
6 LNTH
Lantheus Holdings, Inc.
 261,250 $28,983,071
7 IRWD
Ironwood Pharmaceuticals Inc
 6,465,921 $27,221,524
8 TAK
Takeda Pharmaceutical Co Ltd
 1,525,686 $24,456,745

All Filings in AMRX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,761,931 795,028
2026-03-31 $10,749,362 864,792
2025-12-31 $13,181,009 1,046,112
2025-09-30 $10,150,298 1,014,016
2025-06-30 $8,244,556 1,019,105
2025-03-31 $6,247,077 745,475
2024-12-31 $2,667,439 336,798
2024-09-30 $2,523,063 303,253
2024-06-30 $2,762,769 435,082
2024-03-31 $4,583,704 756,387
2023-12-31 $5,030,505 828,749
2023-09-30 $3,965,306 939,646
2023-06-30 $6,684,350 2,156,242
2023-03-31 $4,185,153 3,010,902
2022-12-31 $4,251,141 2,136,252
2022-09-30 $1,963,765 972,161
2022-06-30 $929,631 292,337
2022-03-31 $988,281 236,998